A G protein-coupled receptor for the pineal hormone melatonin was recently cloned from mammals and designated the Mel,a melatonin receptor. We now report the cloning of a second G protein-coupled melatonin receptor from humans and designate it the Mellb melatonin receptor.
The pineal hormone melatonin can influence the timing of mammalian circadian rhythms, and it regulates the reproductive alterations that occur in response to changes in day length in seasonally breeding mammals (1) (2) (3) . Melatonin appears to elicit these neurobiological responses through pharmacologically specific, guanine nucleotide binding protein (G protein)-coupled receptors. Receptors for melatonin were initially identified by ligand-binding studies and in vitro autoradiography using the biologically active agonist 2-[125I]iodomelatonin (125I-Mel) (4) (5) (6) .
Recently, a high-affinity melatonin receptor was cloned by expression cloning from Xenopus laevis dermal melanophores (7) . Subsequently, a high-affinity melatonin receptor that was 60% identical at the amino acid level with the frog receptor was cloned from several mammals, including humans, by using a PCR approach based on the frog sequence (8) . The mammalian receptors show >80% amino acid identity with each other and thus appear to be species homologs of the same receptor (8) , designated the Mella melatonin receptor (9) . The Mella receptor is expressed in the hypophyseal pars tuberalis (PT) and hypothalamic suprachiasmatic nuclei (SCN), prominent sites of 1251-Mel binding and presumed sites of the reproductive and circadian actions of melatonin, respectively (ref. 8 ; for review see ref. 10 ).
We now report the isolation and characterization of clone H7,1 which encodes a second G protein-coupled melatonin receptor from humans. This clone is expressed in retina and brain, and it exhibits binding and functional characteristics that are very similar to those of the Mella receptor.
MATERIALS AND METHODS PCRL For PCR with degenerate primers, genomic DNA was subjected to 30 cycles of amplification with 200 nM (final concentration) each of two oligonucleotide primers. Each reaction cycle consisted of incubations at 94°C for 45 sec, 45°C for 2 min, and 72°C for 2 min, with AmpliTaq DNA polymerase (Perkin-Elmer/Cetus). For PCR with specific primers, genomic DNA or first-strand cDNA was subjected to 25 to 35 cycles of amplification using incubations at 94°C for 45 sec, 60°C for 45 sec, and 72°C for 2 or 3 min.
Library Screening. A human genomic library in EMBL-3 SP6/T7 (Clontech) was plated and transferred to Colony Plaque Screen filters (New England Nuclear). The filters were screened under conditions of either high or reduced stringency, as previously described (8) . A phage that hybridized to the probe were plaque-purified. Expression Studies. COS-1 and NIH 3T3 cells were grown as monolayers in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal calf serum, penicillin (50 units/ml), and streptomycin (50 jig/ml), in a 5% C02/95% air atmosphere at 37°C.
For ligand-binding studies, melatonin receptor cDNAs in pcDNA3 were introduced into COS-1 cells by using the DEAE-dextran method (11) . Three days after transfection, medium was removed, and crude membranes were prepared. Binding assays were performed in duplicate in a final volume of 200 ,lI, at 37°C for 60 min. Nonspecific binding was defined by 10 ,uM melatonin. Protein was measured by the method of Bradford (12) . Binding data were analyzed by the LIGAND Program of Munson and Rodbard (13) . cAMP Studies. For cAMP studies, the receptor cDNA in pcDNA3 was introduced into NIH 3T3 cells by using Lipofectamine (GIBCO/BRL). Transformed NIH 3T3 cells resistant to Geneticin (G418; 1.0 mg/ml; GIBCO/BRL) were isolated, and single colonies expressing 125I-Mel binding (>200 fmol/mg of total cellular protein) were isolated.
Transformed NIH 3T3 cells were plated in triplicate on 35-mm dishes. Forty-eight hours later, the cells were washed (twice) with DMEM and preincubated with 250 ,uM 3-isobutyl-1-methylxanthine (IBMX) fThe sequence reported in this paper has been deposited in the GenBank data base (accession no. U25341).
8734
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
with 250 ,uM IBMX for 10 min at 37°C. At the end of treatment, the cells were processed as previously described (8) and assayed for cAMP by radioimmunoassay (New England Nuclear).
Comparative Reverse Transcription (RT)-PCR Analysis. A comparative RT-PCR assay was performed by using a modification of a previously described procedure (14) . Poly(A)+ RNA was purchased from Clontech and 2 ,ug from each tissue was primed with random hexamers and reverse transcribed as previously described (15) (8) .
To obtain the 5' portion of the coding region, a 160-bp fragment encoding the first transmembrane domain of the sheep Mel1a melatonin receptor was used to reprobe the positive genomic clones at reduced stringency (see ref. 8) . A 2.3-kb Sac I fragment of one of the genomic clones hybridized to the sheep receptor fragment and was thus subcloned and sequenced. This Sac I fragment contained the apparent 5' end of the coding region. RT-PCR of RNA from human brain, using specific primers directed at the 5' and 3' ends of the putative coding region, amplified the expected cDNA with the intron removed at the splice sites predicted from genomic analysis, indicating that the putative receptor gene is transcribed. A PCR-generated construct of the coding region, designated H7, was subcloned in pcDNA3 for expression studies and sequence analysis. The deduced amino acid sequence of H7 was identical with the corresponding sequence of the Sac I genomic fragments.
Receptor Structure. H7 encodes a protein of 362 amino acids with a predicted molecular mass of 40,188 Da, not including posttranslational modifications (Fig. 1 Upper). H7 is a member of a newly described melatonin receptor group that is distinct from the other receptor groups (e.g., biogenic amine, neuropeptide, and photopigment receptors) that make up the prototypic G protein-coupled receptor family (7, 8) . Unique features of this group include an NRY sequence just downstream from the third transmembrane domain (rather than DRY) and a NAXXY sequence in transmembrane 7 (rather than NPXXY) (Fig. 1 Lower) . In addition, H7, the mammalian Melia melatonin receptors, and the Xenopus melatonin receptor all have a CYICHS sequence immediately downstream from NRY in the third cytoplasmic loop which is a consensus site for cytochrome c family heme binding (17) . The functional significance of this sequence is not yet known.
Pairwise comparisons of H7, the human Mel,a melatonin receptor, and the Xenopus melatonin receptor reveal "60% amino acid identity for any pair of the three sequences (Fig. 1) . Within the transmembrane domains the amino acid identity among any two of the three sequences is 73%. Within the amino-terminal region there is one consensus site for asparagine-linked glycosylation for H7 (Fig. 1 Lower) III   IV  V  H7 GEEHCKASAFVMGLSVIGSVFNITAIAINRYCY ICHSMAYHRIYRRWHTPLH ICLIWLLTVVALLPNFFVGSLEYDPRIYSCTFIQTASTQYTAAVVVIHFLLPIAVVSFC Human ia GYLHCQVSGFLMGLSVIGSIFNITGIAINRYCYICHSLKYDKLYSSKNSLCYVLLIWLLTLAAVLPNLRAGTLQYDPRIYSCTFAQSVSSAYTIAVVVFHFLVPMIIVIFC Xenopus ,. GNIHCQISGFLMGLSVIGSVFNITAIAINRYCYICHSLRYDKLYNQRSTWCYLGLTWILTI IAIVPNFFVGSLQYDPRIFSCTFAQTVSSSYTITVVVVHFIVPLSVVTFC (Fig. 4) (8) . Thus, the recombinant melatonin receptor is negatively coupled to the cAMP regulatory system. Distribution of H7 mRNA. To assess the tissue distribution of H7 mRNA, a 364-bp fragment of the rat homolog of H7 was cloned from rat brain RNA by RT-PCR; the rat cDNA fragment was 81% identical at the amino acid level with H7 (data not shown; GenBank accession no. U28218). In situ hybridization using an antisense cRNA probe to the rat fragment did not reveal a hybridization signal in PT or SCN, sites which gave a positive hybridization signal in the same in situ run when an antisense cRNA probe to the Melia melatonin receptor was used (8) .
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Because of the apparent low level of receptor transcripts, a comparative RT-PCR assay was used to examine the expression of H7 and the human Melia receptor genes in six human tissues (Fig. 5) . H7 was expressed in retina, with much lower expression in whole brain and hippocampus. The Melia receptor was clearly expressed in whole brain, with just detectable expression in retina and hippocampus. Neither H7 nor Melia receptor mRNA was detected in pituitary, liver, or spleen.
Gene Structure and Chromosomal Localization. Restriction endonuclease mapping and PCR analysis of genomic clones showed that the portion of the gene that encodes H7 is composed of 2 exons, separated by an intron that is -9.0 kb in length. Southern analysis of human genomic DNA digested with several different restriction endonucleases was performed by using a PCR fragment of the second exon of H7 as a hybridization probe. Under high-stringency conditions, we observed single-band patterns, suggesting that H7 is a singlecopy gene (data not shown).
To localize the gene for H7, an intronic PCR assay was developed that would amplify only the human H7 gene. A panel of 43 human-rodent somatic cell hybrids that contained Table 1 . involved in alterations in the specificity of G protein coupling and for other G protein-coupled receptors (27, 28 One feature that distinguishes the Mellb receptor from the Melia receptor is its tissue distribution. The expression of the Mellb receptor in retina suggests that melatonin may exert its effects on mammalian retinal physiology through this receptor. Melatonin inhibits the Ca2+-dependent release of dopamine in rabbit retina through activation of receptors with pharmacologic specificity comparable with that reported here for the Mellb receptor (4, 21) . Melatonin appears to act in the retina to affect several light-dependent functions, including photopigment disc shedding and phagocytosis (22, 23) . It will be important to determine the precise anatomical distribution of the Mellb receptor within mammalian retina and to develop specific pharmacological tools to probe the functions of this receptor in retina.
Our previous studies have shown that the Mella melatonin receptor is expressed in SCN and PT (8) , sites felt to be involved in the circadian and reproductive functions of melatonin, respectively (10) . The discovery of a Mellb receptor which has binding and functional characteristics similar to those of the Melia receptor makes it conceivable that the Mellb receptor also participates in the circadian and/or reproductive actions of melatonin. Even though Mellb receptor mRNA is not detectable by in situ hybridization in rat SCN or PT, it may be present and functional in these or other neural sites at levels not detectable by using standard detection methods.
A second distinguishing feature of the Mellb receptor is its chromosome location. The Mellb melatonin receptor maps to human chromosome 11q21-22, a region syntenic to mouse chromosome 9 in the region of the D2-dopamine receptor (Drd2) and thymus cell antigen 1 (Thyl) loci (24, 25) . This contrasts with the Melia melatonin receptor, which maps to human chromosome 4q35.1 and mouse chromosome 8 (9) . Thus, these two structurally and functionally related melatonin receptors did not evolve by simple tandem duplication of an ancestral gene, but other mechanisms, such as duplication and chromosomal rearrangement, were involved. The human and mouse Mellb receptor genes are located in the same regions as those reported for two other G protein-coupled receptors, the D2-dopamine receptor, as already mentioned, and an orphan receptor that is most homologous to the interleukin 8, type 1, receptor (26) . To our knowledge, no retinal disorders have been mapped to these areas in humans or mice.
An interesting feature common to both the Melia and Mellb receptor genes is the conserved position of the intron splice site in the first cytoplasmic loop. An intron at such a location could lead to alternative splice forms of either of these receptors, thereby altering receptor structure and potentially function. Splice variants have been reported for the D2-dopamine receptor in the third intracellular loop that are
